Novartis acquires IFM Tre
Novartis will add to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics LLC focused...
GHO Capital acquires Sterling Pharma Solutions
European specialist investor in healthcare, GHO Capital, has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture...
Healthtech M&A and IPO Activity
The latest Healthtech M&A and IPO Activity Market Report from Hampleton Partners has revealed a final count of almost 100 deals in the healthtech...
DoseCare acquires Biodose
DoseCare announces its acquisition of Biodose, the UK’s only monitored dosage system (MDS) that accommodates liquid and solid medication. Biodose, a medication management solution,...
UK pharma pressing ahead with M&As in 2019
The UK pharmaceutical industry is pressing ahead with M&A activity and is geared to weather any disruption due to Brexit, according to the results...
Sanofi and Denali join forces on inflammatory disease drugs
Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to be neurological and systemic inflammatory disease...
AstraZeneca divests rights for Nexium and Vimovo to Grünenthal
AstraZeneca has agreed to divest the prescription medicine rights for Nexium in Europe, as well as the global rights (excluding the US and Japan)...
Mundipharma acquires biosimilars development company
The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company, Cinfa...
BioIVT acquires CTLS a UK blood donor facility
BioIVT acquires Clinical Trials Laboratory Services (CTLS), a donor centre and laboratory based in London, UK. BioIVT, is a provider of research models and...
Tusk Therapeutics to be acquired by Roche
Tusk Therapeutics Ltd has been acquired by Roche. Tusk was founded in 2014 by Droia Oncology Ventures, Tusk’s majority shareholder. Under the terms of...
Latest articles
Biotech leader wins PING Innovation Award 2019
Dr Harry Destecroix of Ziylo has won the 2019 Pharmaceutical Industry Network Group (PING) Innovation Award, hosted by pharma and life sciences specialist law...
NICE recommend funding for Spinraza for spinal muscular atrophy
The National Institute for Health and Care Excellence (NICE) has recommended funding for Spinraza (nusinersen) on the National Health Service (NHS). The positive recommendation, subject to...
New data from Novel START trial accepted for presentation
New data from the Symbicort Turbuhaler (budesonide/formoterol) Novel START trial is among 73 AstraZeneca abstracts accepted for oral or poster presentation at the American...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Novartis presents new migraine data for Aimovig®▼ (erenumab)
Novartis presents new migraine data for Aimovig®▼ (erenumab) demonstrating sustained efficacy to 52 weeks. Novartis has announced that new data from two follow-up studies of...
New data from Novel START trial accepted for presentation
New data from the Symbicort Turbuhaler (budesonide/formoterol) Novel START trial is among 73 AstraZeneca abstracts accepted for oral or poster presentation at the American...
Top 5 R&D hubs in the UK
Read this cover story in the June issue of Pf Magazine here. Join us on a tour of inspirational research and development centres. ...
Biotech leader wins PING Innovation Award 2019
Dr Harry Destecroix of Ziylo has won the 2019 Pharmaceutical Industry Network Group (PING) Innovation Award, hosted by pharma and life sciences specialist law...